These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 6430038)

  • 21. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral contraceptives and back pain in women in a Swedish community.
    Wreje U; Isacsson D; Aberg H
    Int J Epidemiol; 1997 Feb; 26(1):71-4. PubMed ID: 9126505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reporting of malformations in routine health registers.
    Hemminki E; Meriläinen J; Teperi J
    Teratology; 1993 Sep; 48(3):227-31. PubMed ID: 8248860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fertility after contraception or abortion.
    Huggins GR; Cullins VE
    Fertil Steril; 1990 Oct; 54(4):559-73. PubMed ID: 2209874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits and risks of oral contraceptive use.
    Williams RS
    Postgrad Med; 1992 Nov; 92(7):155-7, 161-2, 168-71. PubMed ID: 1437913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
    Realini JP; Encarnacion CE; Chintapalli KN; Rees CR
    J Am Board Fam Pract; 1997; 10(5):315-21. PubMed ID: 9297655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism.
    Bennet L; Odeberg H
    J Intern Med; 1998 Jul; 244(1):27-32. PubMed ID: 9698021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
    Farmer RD; Todd JC; Lewis MA; MacRae KD; Williams TJ
    Contraception; 1998 Feb; 57(2):67-70. PubMed ID: 9589831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
    Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraceptive risks: a realistic appraisal.
    Bressler R; Durand JL
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden.
    Olsson H; Möller TR; Ranstam J
    J Natl Cancer Inst; 1989 Jul; 81(13):1000-4. PubMed ID: 2733043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biguanide-induced lactic acidosis in Finland.
    Korhonen T; Idänpään-Heikkilä J; Aro A
    Eur J Clin Pharmacol; 1979 Jul; 15(6):407-10. PubMed ID: 499289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-marketing surveillance of oral contraceptives.
    Alberman E
    Hum Reprod; 1986 Nov; 1(7):433-4. PubMed ID: 3106401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral contraceptive use and premenopausal breast cancer in Sweden and Norway: possible effects of different pattern of use.
    Lund E; Meirik O; Adami HO; Bergstrøm R; Christoffersen T; Bergsjø P
    Int J Epidemiol; 1989 Sep; 18(3):527-32. PubMed ID: 2807653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective prescribing of third generation oral contraceptives (OCs).
    Jamin C; de Mouzon J
    Contraception; 1996 Jul; 54(1):55-6. PubMed ID: 8804809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway.
    Meirik O; Lund E; Adami HO; Bergström R; Christoffersen T; Bergsjö P
    Lancet; 1986 Sep; 2(8508):650-4. PubMed ID: 2876135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral contraception and circulatory risks].
    Wingrave SJ
    Contracept Fertil Sex (Paris); 1984 Oct; 12(10):1111-6. PubMed ID: 12266560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.